77,086 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Purchased by TIG Advisors LLC

TIG Advisors LLC bought a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 77,086 shares of the pharmacy operator's stock, valued at approximately $719,000.

Several other institutional investors and hedge funds have also made changes to their positions in WBA. Vanguard Group Inc. raised its holdings in shares of Walgreens Boots Alliance by 2.7% in the fourth quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator's stock valued at $805,506,000 after acquiring an additional 2,279,495 shares in the last quarter. Invesco Ltd. raised its holdings in shares of Walgreens Boots Alliance by 8.8% in the fourth quarter. Invesco Ltd. now owns 32,572,567 shares of the pharmacy operator's stock valued at $303,902,000 after acquiring an additional 2,631,332 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Walgreens Boots Alliance by 5.2% in the fourth quarter. Geode Capital Management LLC now owns 20,779,254 shares of the pharmacy operator's stock valued at $194,082,000 after acquiring an additional 1,020,587 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in Walgreens Boots Alliance by 19.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator's stock worth $122,737,000 after purchasing an additional 2,185,950 shares in the last quarter. Finally, Northern Trust Corp raised its holdings in Walgreens Boots Alliance by 18.8% in the fourth quarter. Northern Trust Corp now owns 8,896,742 shares of the pharmacy operator's stock worth $83,007,000 after purchasing an additional 1,407,973 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have commented on WBA. Wolfe Research upgraded shares of Walgreens Boots Alliance to a "hold" rating in a report on Monday, February 24th. Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a "hold" rating to a "sell" rating and dropped their price target for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Evercore ISI boosted their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an "in-line" rating in a research note on Monday, January 13th. Bank of America boosted their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an "underperform" rating in a research note on Monday, January 13th. Finally, Royal Bank of Canada boosted their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a "sector perform" rating in a research note on Wednesday, January 15th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $10.59.

Insider Buying and Selling at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Chairman Stefano Pessina purchased 832,258 shares of the stock in a transaction that occurred on Sunday, April 27th. The shares were purchased at an average cost of $11.01 per share, for a total transaction of $9,163,160.58. Following the completion of the transaction, the chairman now owns 145,621,079 shares of the company's stock, valued at $1,603,288,079.79. The trade was a 0.57 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. 17.50% of the stock is owned by corporate insiders.

Walgreens Boots Alliance Stock Performance

WBA traded down $0.04 on Thursday, reaching $10.93. The stock had a trading volume of 7,878,674 shares, compared to its average volume of 21,044,243. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $18.83. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The business's 50-day moving average price is $10.98 and its two-hundred day moving average price is $10.26. The company has a market cap of $9.45 billion, a P/E ratio of -1.07, a price-to-earnings-growth ratio of 1.31 and a beta of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, beating analysts' consensus estimates of $0.53 by $0.10. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company had revenue of $38.59 billion during the quarter, compared to analysts' expectations of $37.90 billion. During the same quarter in the previous year, the company earned $1.20 earnings per share. The firm's revenue for the quarter was up 4.1% on a year-over-year basis. Sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.